
Teva Pharmaceutical (TEVA) Earnings Dates & Reports
Teva Pharmaceutical (TEVA) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS$0.67
Actual EPS$0.78
EarningsBeat
Teva Pharmaceutical (TEVA) Earnings
View the latest Teva Pharmaceutical (TEVA) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Teva Pharmaceutical (TEVA)
Order type
Buy in
Order amount
Est. shares
0 shares
Teva Pharmaceutical (TEVA) Earnings per Share (EPS) History
Signup for full accessBrowse free
Teva Pharmaceutical (TEVA) Latest Earnings
The value each TEVA share was expected to gain vs. the value each share gained.
Teva Pharmaceutical (TEVA) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of $0.78. This exceeded analysts' expectations of $0.67 by 16.42%, marking a Beat.
For comparison, Teva Pharmaceutical reported EPS of $0.69 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.65.
Teva Pharmaceutical (TEVA) Earnings History
Teva Pharmaceutical (TEVA) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Teva Pharmaceutical’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Teva Pharmaceutical (TEVA) Earnings FAQs
Teva Pharmaceutical (TEVA) last reported earnings on Nov 5, 2025 for Q3 2025, posting an EPS of $0.78, which Beat the estimate of $0.67 by 16.42%.
For Q3 2025, Teva Pharmaceutical (TEVA) reported an EPS of $0.78, exceeding analysts' estimate of $0.67 by 16.42%.
For Q3 2025, Teva Pharmaceutical (TEVA) Beat expectations with an actual EPS of $0.78 vs. an estimated EPS of $0.67.
Following the last earnings report on Nov 5, 2025, Teva Pharmaceutical (TEVA)'s stock price moved — from — to —.
The next Teva Pharmaceutical (TEVA) earnings call is scheduled for Jan. 28, 2026, where executives will discuss financial results and outlook.